Corante

About this author
Zack Lynch Zack Lynch is the founder and executive director of the Neurotechnology Industry Organization (NIO) and co-founder of NeuroInsights. He serves on the advisory boards of the McGovern Institute for Brain Research at MIT,Center for Cognitive Liberty & Ethics, the InnerSpace Foundation, the Center for Neuroeconomic Studies and SocialText, a social software company. His book on how brain science is changing our world will be available July 2009. Please send newsworthy items or feedback - to Zack Lynch.
Receive by email

GUEST AUTHOR ARCHIVES
Check out Jevon MacDonald on the "uncertain future of blogging"

Brain Waves

« Keep Your Pulse on Mental Health Issues | Main | Science and Society Weekly Internet Radio Program »

January 6, 2005

New Web-based Treatment Tool for Schizophrenia

Email This Entry

Posted by Zack Lynch

Psychnotes reports on a "new Web-based treatment algorithm will be available in January 2005 to help clinicians determine the best medication for patients with schizophrenia. A team of international psychopharmacologists led by Herbert Meltzer, MD of Vanderbilt University Medical Center recently completed the new algorithm designed to offer clinicians a resource as they make treatment decisions.

The project is part of the International Psychopharmacology Algorithm Project (IPAP) with the goal of developing new Web-based tools to improve the treatment of psychiatric disorders.

Comments (1) + TrackBacks (0) | Category: Neurodevices


COMMENTS

1. Trapier K. Michael on January 7, 2005 8:41 PM writes...

It's "Vanderbilt" my Lynch, without a "u".

Trapper

www.isemmelweis.com

Permalink to Comment


EMAIL THIS ENTRY TO A FRIEND

Email this entry to:

Your email address:

Message (optional):




RELATED ENTRIES
NIO Unveils Top 10 Neuroscience Trends for 2009
NIO CEO Media Tour in NYC Gets Results
O Neurocaster
Manuscript Sent to Japan
2009 Stem Cell Trendsetters in Neurology and Psychiatry
Mental Health Parity Legislation Passes within Financial Package
Holy Neurofinancial Meltdown Bernanke
Interest in Neuropolicy Grows